The adoption of artificial intelligence in the pharmaceutical industry is transforming the way drugs are discovered, developed, and brought to market. Generative AI, in particular, is playing a crucial role in accelerating the drug discovery process, making it faster, more accurate, and cost-effective. Kimberly Powell, VP and general manager of healthcare at NVIDIA, shares her insights on how generative AI is being applied to the drug discovery process, from understanding the languages of biology and chemistry to identifying new drug candidates and optimizing the screening process. With the help of generative AI, pharmaceutical companies like Insilico Medicine are able to develop new drugs at a fraction of the cost and time, paving the way for quicker cures for diseases. This technology has the potential to revolutionize the healthcare and pharmaceutical sectors, and its impact will be felt for years to come.
Revolutionizing Drug Discovery with Generative AI
We can now take these languages … and we can apply the method of generative AI and GPT-type methods … Once we do that, the language models can really help us understand a lot more about biology that maybe we haven’t been able to observe in the real world.
1–2 minutes
TOP STORIES
Quantum computing is transforming industries, but it poses significant cybersecurity risks …
A coalition of state attorneys general has opened an investigation into OpenAI …
The U.S. government’s export control directive has forced Anthropic to disable its new AI models, raising questions about regulation and …
SpaceX’s recent deal with Google highlights its shift from aerospace to AI infrastructure …
Google is suing to dismantle the infrastructure behind an alleged massive AI-powered cybercrime operation …
AI usage continues to grow rapidly, even as public sentiment remains skeptical …
